ArticleCNS neuroscience & therapeutics2026
Subcutaneous Neuromodulation Activates Central Pain-Suppression Pathways for Analgesia.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
aimsPeripheral neuromodulation, which can be considered a flow of signals from the body to the brain, induces pain relief. However, whether subcutaneous neuromodulation, which regulates specific neural circuits for analgesia, remains largely elusive. This study aimed to evaluate the analgesic effects of subcutaneous mechanical stimulation (SMS) on neuropathic pain.
methodsA stainless-steel needle (0.5 cm long) was inserted into the subcutaneous tissue. Mechanical allodynia, thermal hyperalgesia, and conditioned place preference (CPP) were assessed in rodent models of localized inflammation of the dorsal root ganglia (LID) and spared nerve injury (SNI). Optogenetic and chemogenetic tools were employed in conjunction with electrophysiological recordings, molecular analyses, and pharmacological interventions to elucidate the underlying mechanisms of SMS-induced analgesia.
resultsSubcutaneous needle insertion generated mechanical force, activating Piezo channels. SMS attenuated mechanical allodynia and thermal hyperalgesia and induced CPP in the LID and SNI models. Naloxone pretreatment did not significantly affect SMS-induced analgesia. SMS activated GABAergic neurons in the NAc shell, and their inhibition reversed the SMS effects in LID rats. Furthermore, activation of the IL-to-nucleus accumbens (NAc) shell projections was essential for SMS-induced analgesia and CPP.
conclusionThese findings indicate that SMS activates central pain-suppression pathways, providing a potential framework for clinical pain management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.